Turing Pharmaceuticals is being sued for more than $20 million by the drug maker that sold it the rights to Daraprim.
By Ed Silverman, STAT
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.